Hemophilia Drugs Market 2019 Analysis, Exhibit 6.0% CAGR and Remarkable Growth Rate forecast till 2025

Hemophilia Drugs Market is projected for better diagnosis because patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process, Hemophilia Drugs Industry exhibit a 6.0% & strong growth in the coming years

pune, india - May 16, 2019 /MarketersMedia/ —

The Global Hemophilia Drugs Market covered a value of US$ 9875.4 Mn in the year 2017 and is anticipated to reach US$ 15830.3 Mn by 2025. Furthermore, the global market for hemodialysis is expected to report a CAGR of 6.0% during the forecast period. The above information was published in a report, titled “Hemophilia Drugs Market Size, Share and Global Trend by Disease Indication (Hemophilia A, B & C), Therapy Type (Recombinant Therapy, Plasma therapy & Others), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2025.”

The rising prevalence of severe diseases is one of the major concerns in the healthcare industry. Among these disorders, patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process. Companies are introducing novel hemophilia drugs and therapies to fulfil the unmet needs of patients and maintain their quality of life. A lead analyst at Fortune Business Insights said, “Companies are building expansion strategies to develop new hemophilia drugs so as to offer better diagnosis.”

Among disease indications, hemophilia A is projected to exhibit a strong growth in the coming years. In addition to this, this segment covered a share of 85% in the global hemophilia drugs market in 2017. This is mainly attributable to the rising pool patients suffering from hemophilia across the world. Also, rising initiatives at developing and commercializing new products for the effective treatment of hemophilia is driving this segment’s growth. Following hemophilia A, hemophilia B drugs are also expected to grow at a considerable rate in the years to come.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/hemophilia-drugs-market-100068

Asia Pacific to Grow at a Rapid Pace with Rising Number of Hemophilia Patients

North America is projected to emerge dominant in the global hemophilia drugs market during the forecast period. This is mainly ascribable to the rising prevalence of hemophilia A and B, especially in countries such as Canada and the U.S. Moreover, in 2017, North America market for hemophilia drugs covered a value of US$ 3,684.7 Mn. Trailing North America, Europe is the second-leading region in the global hemophilia drugs market. The growth in this region is attributable to the rising healthcare budgets by governments and initiatives by governments to promote hemophilia drugs treatment. On the other hand, the hemophilia drugs market in Asia Pacific is likely to expand at a higher CAGR between 2017 and 2025 on account of rising number of patients suffering from hemophilia especially in countries such as China and India.

Rising Awareness About Hemophilia to Augment the Demand

The primary factor augmenting the hemophilia drugs market is the recent developments in hemophilia treatment. A lead analyst at Fortune Business Insights said “Several new drugs are expected to enter the global market in the coming years.” Also, hemophilia surgical management is gaining traction on account of increasing awareness about hemophilia across the world. Moreover, governments are planning to conduct awareness initiatives to spread knowledge regarding the use of hemophilia treatment and drugs This, in turn, is expected to drive the hemophilia drugs market over the next few years. The genetic evolution is leading to rising incidences of bleeding disorders across the world. This will further lead to hemophilia drug development in the next few years to come. As per the study conducted by the National Hemophilia Foundation or NHF in 2015, about 1% of the U.S. population is likely to suffer from a disease called von Willebrand, hence rising the need for hemophilia treatment drugs.

Pfizer Introduced Gene Therapy to Address Unmet Patient’s Needs

Some of the leading players presently operating in the global market for hemophilia drugs are Grifols SA, Bioverativ Inc., FERRING LÄKEMEDEL AB, Aptevo Therapeutics, Hoffmann-La Roche Ltd, Novo Nordisk, Pfizer, Inc. and CSL Behring. In 2018, companies such as Novo Nordisk, Takeda Pharmaceutical Company Ltd., and F. Hoffmann-La Roche Ltd covered more than half of the share in the global hemodialysis market as per revenue. In 2017, Pfizer, Inc. collaborated with Sangamo Therapeutics, Inc. to commercialize and develop gene therapy programs. The aim was to utilize these programs for Hemophilia A drugs.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/hemophilia-drugs-market-100068

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: 1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/hemophilia-drugs-market-2019-analysis-exhibit-60-cagr-and-remarkable-growth-rate-forecast-till-2025/513243

Source: MarketersMedia

Release ID: 513243

Latest News

UK: Europe-led mission will protect vital shipping in Gulf

Jul 23, 2019

LONDON — Britain announced plans Monday to develop and deploy a Europe-led "maritime protection mission" to safeguard shipping in the vital Strait of Hormuz in light of Iran's seizure of a British-flagged tanker in the waterway last week. Briefing Parliament on the budding crisis, Foreign Secretary Jeremy Hunt accused Iran of "an act of state piracy" that must be met with a coordinated international reaction. Iranian officials have suggested the Stena Impero was seized and taken to an Iranian port in response to Britain's role in seizing an Iranian oil tanker two weeks earlier off the coast of Gibraltar, a...

British Airways, Lufthansa suspend Cairo flights

Jul 23, 2019

LONDON — British Airways and Lufthansa both said Saturday they were suspending flights to Cairo for unspecified reasons related to safety and security. The British carrier said it was canceling flights to the Egyptian capital for a week. The German airline said normal operations would resume Sunday. Both carriers delivered two-sentence statements via email. British Airways attributed its cancellations to what it called its constant review of security arrangements at all airports, calling them "a precaution to allow for further assessment." Lufthansa said it was suspending its flights as a precaution, mentioning "safety" but not "security" as its concern. Company...

Codebreaker Alan Turing to be face of new British banknote

Jul 23, 2019

LONDON — Codebreaker and computing pioneer Alan Turing has been chosen as the face of Britain's new 50 pound note, the Bank of England announced Monday. Governor Mark Carney said Turing, who did ground-breaking work on computers and artificial intelligence, was "a giant on whose shoulders so many now stand." During World War II Turing worked at the secret Bletchley Park code-breaking center, where he helped crack Nazi Germany's secret codes by creating the "Turing bombe," a forerunner of modern computers. He also developed the "Turing Test" to measure artificial intelligence. After the war he was prosecuted for homosexuality, which...

Heather Mills gets UK phone hacking apology, payout

Jul 23, 2019

LONDON — Heather Mills, the former wife of Paul McCartney, and her sister have received an apology and a settlement from Britain's defunct News of the World tabloid over the hacking of their phones. Heather Mills and her sister Fiona Mills both received a formal apology in Britain's High Court on Monday. In a statement read outside the court, she said she felt "joy and vindication" at the settlement. "My motivation to win this decade-long fight stemmed from a desire to obtain justice, not only for my family, my charities and myself, but for the thousands of innocent members of...

Report: Hackers using telecoms like 'global spy system'

Jul 23, 2019

LONDON — An ambitious group of suspected state-backed hackers has been burrowing into telecommunications companies in order to spy on high-profile targets across the world, a U.S. cybersecurity firm said in a report published Tuesday . Boston-based Cybereason said the tactic gave hackers sweeping access to VIPs' call records, location data and device information — effectively turning the targets' cellular providers against them. Cybereason Chief Executive Lior Div said because customers weren't directly targeted, they might never discover that their every movement was being monitored by a hostile power. The hackers have turned the affected telecoms into "a global surveillance...

Sign up now!

About Us

Future Science Today reports on captivating developments in science, medicine, technology, and the world around us.

Contact us: sales[at]futuresciencetoday.com